Priapism associated with concurrent use of phosphodiesterase inhibitor drugs and intracavernous injection therapy

International Journal of Impotence Research

Volumn 15, Issue 5, 2003, Pages 383-384

  McMahon, C G ^a  

^a Australian Centre for Sexual Health   (Australia)

Author keywords

Erectile dysfunction; Penile injections; Priapism; Sildenafil; Tadalafil

Indexed keywords

PHOSPHODIESTERASE INHIBITOR; PROSTAGLANDIN E1; SILDENAFIL; TADALAFIL;

ADULT; ARTICLE; CASE REPORT; ECHOGRAPHY; ERECTILE DYSFUNCTION; HUMAN; MALE; PENILE BLOOD FLOW; PRIAPISM; PRIORITY JOURNAL;

ADULT; ALPROSTADIL; DRUG THERAPY, COMBINATION; HUMANS; IMPOTENCE; MALE; MIDDLE AGED; PAPAVERINE; PHENTOLAMINE; PHOSPHODIESTERASE INHIBITORS; PIPERAZINES; PRIAPISM; VASODILATOR AGENTS;

EID: 0242499493     PISSN: 09559930     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijir.3901046     Document Type: Article

References (12)

1. Brock GB et al. Efficacy and safety of tadalafil for the treatment of erectile dysfunction: results of integrated analyses. J Urol 2002; 168: 1332.
2. Morales A et al. Clinical safety of oral sildenafil citrate (VIAGRA) in the treatment of erectile dysfunction. Int J Impot Res 1998; 10: 69.
3. Porst HJ. The rationale for prostaglandin E1 in erectile failure: a survey of worldwide experience. Urology 1996; 155: 802.
4. McMahon C. A comparison of the response to the intracavernasal injection of a combination of papaverine and phentolamine, prostaglandin PGE1 and a combination of all three in the management of impotence. Int J Impot Res 1991; 3: 113.
5. Sur RL Kane CJ. Sildenafil citrate-associated priapism. Urology 2000; 55: 950.
6. Aoyagi T et al. Sildenafil induced priapism. Bull Tokyo Dent Coll 1999; 40: 215.
7. Kassim AA, Fabry ME, Nagel RL. Acute priapism associated with the use of sildenafil in a patient with sickle cell trait. Blood 2000; 95: 1878.
8. Goldmeier D, Lamba H. Prolonged erections produced by dihydrocodeine and sildenafil. BMJ 2002; 324: 1555.
9. McMahon CG, Samali R, Johnson H. Efficacy, safety and patient acceptance of sildenafil citrate as a treatment for erectile dysfunction. J Urol 2000; 164: 1192.
10. Hatzichristou DG et al. Sildenafil versus intracavernous injection therapy: efficacy and preference in patients on intracavernous injection for more than 1 year. J Urol 2000; 164: 1197.
11. McMahon CG, Samali R, Johnson H. Treatment of intracorporeal injection nonresponse with sildenafil alone or in combination with triple agent intracorporeal injection therapy. J Urol 1999; 162: 1992.
12. Yoon H et al. Intracavernosal injection of sildenafil citrate: misapplication of the drug. J Urol 2001; 165: 1218.